Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

J Natl Cancer Inst. 2002 Apr 17;94(8):630-1; author reply 631-2. doi: 10.1093/jnci/94.8.630.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alleles
  • Catalysis
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P-450 Enzyme System / metabolism
  • Genetic Markers
  • Humans
  • Liver / metabolism
  • Male
  • Mixed Function Oxygenases / genetics*
  • Mixed Function Oxygenases / metabolism
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / genetics*

Substances

  • Genetic Markers
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human